SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

ROSICH, Isabel et al. Eficiencia en la prescripción de medicamentos: impacto de un programa de intercambio terapéutico. Gac Sanit [online]. 2012, vol.26, n.1, pp. 58-64. ISSN 0213-9111.  http://dx.doi.org/10.1590/S0213-91112012000100010.

    1. Organizacin Mundial de la Salud. Uso racional de los medicamentos: informe de la Conferencia de Expertos (1985). Nairobi: Ginebra: OMS; 2001. [ Links ]

    2. Gray T, Bertch K, Galt K, et al. Guidelines for therapeutic interchange. 2004. American College of Clinical Pharmacy. Pharmacotherapy. 2005; 25:1666-80. [ Links ]

    3. Programa de intercambio teraputico. Manual de procedimientos para su redaccin. Grupo Gnesis. Sociedad Espaola de Farmacuticos de Hospital. Disponible en: http://genesis.sefh.es/Documents/programadeintercambioterapeutico_VersionPreliminar1.doc. [ Links ]

    4. Puigvents F, Ventayol P, Delgado O. Intercambio teraputico. En: Farmacia Hospitalaria. Tomo I. 2004. p. 101-11. [ Links ]

    5. Delgado Snchez O, Puigvents Latorre F, Ventayol Bosch P. Equivalentes teraputicos. Concepto y casos prcticos. Formacin Continuada para Farmacuticos de Hospital II. 2003; 77-99. [ Links ]

    6. American Society of Consultant Pharmacists. ASCP guidelines for implementing therapeutic interchange in long-term care. July 18, 1997. p. 1-5. [ Links ]

    7. American Society of Health-System Pharmacists. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. Am J Health-Syst Pharm. 2008; 65:1272-83. [ Links ]

    8. Programas y guas para el intercambio teraputico. Grupo Gnesis. Sociedad Espaola de Farmacuticos de Hospital. Disponible en: http://genesis.sefh.es/Enlaces/programa.de.intercambioterapeuticos.Hospitales.htm. [ Links ]

    9. Cresp Monjo M, Delgado Snchez O, Ventayol Bosch P, et al. Estudio prospectivo y aleatorizado de intercambio teraputico de sulfonilureas en pacientes con diabetes mellitus tipo 2. Farm Hosp. 2004; 28:426-32. [ Links ]

    10. Mercadal Orfila G, Berlana Martn D, De la Pea Oliete MD, et al. Intercambio teraputico de sulfonilureas en un hospital de tercer nivel: aplicacin y evaluacin clnica del protocolo. Rev Cubana Farm. 2005; 39. [ Links ]

    11. Peris Mart JF, Faus Felipe VJ, De la Vega Ortega , et al. Intercambio teraputico de antagonistas del receptor de la angiotensina-II en pacientes ancianos institucionalizados. Aplicacin de un protocolo. Farm Hosp. 2003; 27:290-7. [ Links ]

    12. Guia Farmacoteraputica i d'Intercanvi Teraputic Atenci Especialitzada-Atenci Primria. Regi Sanitria de Lleida. Disponible en: http://www10.gencat.net/catsalut/archivos/publicacions/farmacia/farmacrslle07.pdf. [ Links ]

    13. Calvo C, Vilanova M. Gua farmacoteraputica interniveles de Illes Balears. El Comprimido. 2007; no 10. Disponible en: http://www.elcomprimido.com/GFIB/pdf/GFT_interniveles_pdf.pdf. [ Links ]

    14. Hysong SJ. Meta-analysis: audit and feedback features impact effectiveness on care quality. Med Care. 2009; 47:356-63. [ Links ]

    15. Jamtvedt G, Young JM, Kristoffersen DT, et al. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews. 2006, doi:10.1002/14651858.CD000259.pub2. Art. No.: CD000259. [ Links ]

    16. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004; 8:1-84. [ Links ]

    17. Ostini R, Hegney D, Jackson C, et al. Systematic review of interventions to improve prescribing. An Pharmacother. 2009; 43:502-13. [ Links ]

    18. Inhibidores de la bomba de protones. Notas Farmacoteraputicas. 2007;14:23-28. Servicio Madrileo de Salud. Disponible en: http://www.infodoctor.org/notas/NF-2007-7.InhibidoresBombaProtones.pdf. [ Links ]

    19. Revisi sistemtica de les avaluacions econmiques dels diferents inhibidors de la bomba de protons (IBP) comercialitzats a Espanya. Comissi d'Avaluaci Econmica i Impacte Pressupostari (CAEIP), gener de 2007. Servei Catal de la Salut. Disponible en: http://www10.gencat.cat/catsalut/archivos/farmacia/CAEIP/caeip_rev_sis_ibp.pdf. [ Links ]

    20. lvarez Arroyo L, Bellver Martnez M, Calvo Pita C, et al. Recomendaciones para la prescripcin de los inhibidores de la bomba de protones en el medio ambulatorio. Servei de Salut de les Illes Balears. Junio de 2010. Disponible en: http://www.elcomprimido.com/PDF/documento recomendaciones empleo IBP.pdf. [ Links ]

    21. Estndard de qualitat de prescripci farmacutica dels equips d'atenci primria 2010. Unitat de Coordinaci i Estratgia del Medicament. Institut Catal de la Salut. Disponible en: http://www.gencat.cat/ics/professionals/pdf/EQPF_MFIC_pediatria_odontologia_2010.pdf. [ Links ]

    22. Lucas L, Gerrity MS, Anderson T. Practice-based approach for converting from proton pump inhibitors to less costly therapy. Eff Clin Pract. 2001; 4:263-70. [ Links ]

    23. Hess G, Sanders KN, Hill J, et al. Therapeutic dose assessment of patient switching from atorvastatin to simvastatin. Am J Manag Care. 2007; 13(Suppl 3):S80-5. [ Links ]

    24. Kereiakes DJ, Willerso JT. Therapeutic substitution guilty until proven innocent. Circulation. 2003; 108:2611-2. [ Links ]

    25. Antman EM, Ferguson JJ. Should evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents?. Circulation. 2003; 108:2604-7. [ Links ]

    26. Furberg CD, Psaty BM. Should evidence-based proof of drug efficacy be extrapolated to a "class of agents"?. Circulation. 2003; 108:2608-10. [ Links ]

    27. Nelson WW, Vermeulen LC, Geurkink EA, et al. Clinical and humanistic outcomes in patients with gastroesophageal reflux disease converted from omeprazole to lansoprazole. Arch Intern Med. 2000; 160:2491-6. [ Links ]

    28. Batuwitage BT, Kingham JGC, Morgan NE, et al. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J. 2007; 83:66-8. [ Links ]

    29. Burgos C, Novo del Castillo S, Llorente E, et al. Estudio prescripcin-indicacin de inhibidores de la bomba de protones. Rev Clin Esp. 2006; 206:266-70. [ Links ]

    30. Forgacs I. Overprescribing proton pump inhibitors. Is expensive and not evidence based. BMJ. 2008; 336:2-3. [ Links ]

    31. Inhibidores de la bomba de protones, se puede vivir sin ellos? Informacin Farmacoteraputica de la Comarca. 2010;18:11-6. Centro Vasco de Informacin de Medicamentos CEVIME-MIEZ. Osakidetza. Disponible en: http://www.euskadi.net/r33-2288/es/contenidos/informacion/cevime_infac/es_cevime/adjuntos/infac_v18_n3.pdf. [ Links ]